| Index | Ligand Name | Structure | PDB code | ligand desolvation |
| 1 | 5ty | Crystal structure of the BRD9 bromodomain in complex with compound 3. | 5f2p | 79.06 |
| 2 | i0d | BROMODOMAIN OF HUMAN BRD9 WITH 4-chloro-2-methyl-5-((2-methyl-1,2,3,4-tetrahydroisoquinolin-5-yl)amino)pyridazin-3(2H)-one | 5mky | 77.66 |
| 3 | 5u2 | Crystal structure of the bromodomain of BRD9 in complex with compound 9. | 5f1l | 74.89 |
| 4 | 5u6 | Crystal structure of the BRD9 bromodamian in complex with BI-9564. | 5f1h | 73.03 |
| 5 | bmf | Crystal structure of the bromodomain of human BRD9 in complex with bromosporine (BSP) | 5igm | 71.61 |
| 6 | 67c | BRD9 bromodomain in complex with 3-(6-(but-3-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-N,N-dimethylbenzamide | 6bqa | 71.21 |
| 7 | 5sw | CRYSTAL STRUCTURE OF BRD9 IN COMPLEX WITH BI-7273 | 5eu1 | 70.43 |
| 8 | 69g | BRD9 in complex with Cpd4 ((E)-3-(6-(but-2-en-1-yl)-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)-N,N-dimethylbenzamide) | 5i7y | 69.86 |
| 9 | tvu | BROMODOMAIN OF HUMAN BRD9 WITH 7-(3,4-dimethoxyphenyl)-N-(1,1-dioxo-1- thian-4-yl)-5-methyl-4-oxo-4H,5H-thieno-3,2-c-pyridine-2-carboxamide | 4uiu | 67.94 |
| 10 | h1b | BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-ethyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide | 4uiw | 67.27 |
| 11 | xzb | BROMODOMAIN OF HUMAN BRD9 WITH N-(1,1-dioxo-1-thian-4-yl)-5-methyl-4- oxo-7-3-(trifluoromethyl)phenyl-4H,5H-thieno-3,2-c-pyridine-2- carboximidamide | 4uiv | 66.41 |
| 12 | 6b2 | Crystal structure of human BRD9 bromodomain in complex with LP99 chemical probe | 5ign | 65.54 |
| 13 | n1d | BROMODOMAIN OF HUMAN BRD9 WITH 7-(3,4-dimethoxyphenyl)-2-(4- methanesulfonylpiperazine-1-carbonyl)-5-methyl-4H,5H-thieno-3,2-c- pyridin-4-one | 4uit | 65.09 |